You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 10, October 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immunodeficiency-Associated Thrombocytopenic Purpura (IDTP)

Response to Splenectomy

Peter A. Schneider, MD; Donald I. Abrams, MD; Anthony A. Rayner, MD; David C. Hohn, MD

Arch Surg. 1987;122(10):1175-1178.


Abstract

• Immunodeficiency-associated thrombocytopenic purpura (IDTP) is a feature of the acquired immunodeficiency syndrome—related complex. Current therapeutic modalities for IDTP include splenectomy and the administration of corticosteroids or other agents. Empiric treatment of IDTP has been analogous to that for immunologic thrombocytopenic purpura (ITP). The present report reviews 15 patients who underwent splenectomy for IDTP, demonstrates the successful use of surgical therapy, and defines our indications for splenectomy in the treatment of this disorder. Thirteen of 15 patients had initially failed to respond to steroid therapy. Fourteen patients (93%) initially responded to splenectomy, with platelet counts increasing to 150 x 109/L (150 000/mm3) or greater. A continuing complete response was achieved in nine patients (60%) following splenectomy. After postsurgical adjunctive therapy, durable remission was achieved in 73% (11/15) of the patients. Complications occurred in three patients, and there were no deaths. The mean follow-up was 12.4 months. Splenectomy may be performed in the treatment of IDTP with acceptable morbidity and likelihood of response.

(Arch Surg 1987;122:1175-1178)



Author Affiliations

From the Departments of Surgery (Drs Schneider, Rayner, and Hohn) and Medicine (Dr Abrams), University of California—San Francisco.


Footnotes

Accepted for publication Oct 27, 1986.

Reprint requests to Room HSE 585, University of California, San Francisco, CA 94143 (Dr Hohn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Splenectomy for HIV-Related Immune Thrombocytopenia: Comparison With Results of Splenectomy for Non-HIV Immune Thrombocytopenic Purpura
Lord et al.
Arch Surg 1998;133:205-210.
ABSTRACT | FULL TEXT  

Effect of Splenectomy on Slowing Human Immunodeficiency Virus Disease Progression
Tsoukas et al.
Arch Surg 1998;133:25-31.
ABSTRACT | FULL TEXT  

A Growing Spectrum of Surgical Disease in Patients With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Experience With 120 Major Cases
Diettrich et al.
Arch Surg 1991;126:860-866.
ABSTRACT  

Immune Thrombocytopenia in Hemophiliacs Infected With Human Immunodeficiency Virus and Their Response to Splenectomy
Kim et al.
Arch Intern Med 1989;149:1685-1688.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.